Recent epidemiologic studies show that exposures to particulate air pollution, far below the current National Ambient Air Quality Standards, are associated with increased morbidity mortality in people with cardiopulmonary disease. This project focuses upon discovery of mechanisms by which inhaled ambient particles may produce such effects. Studies from our laboratories have shown: 1) inhalation of concentrated ambient particles (CAPs) results in as high as 37 percent mortality in animals with pre-existing pulmonary inflammation, but no mortality and no detectable effects on the lungs of normal anamils; 2) with exposure to environmental particles, suing our sensitive technology, significant cardiac electrophysiologic alterations are found even in normal animals; 3) CAPs initiate production of oxidants and cytokines in inflammation-primed lung cells comparable in magnitude to highly toxic alpha-quartz, and reactive oxygen species directly induce pro-inflammatory cytokines. Concepts basic to our approach are: 1) ambient air particles should be used for study; 2) the exposed populations should model affected human populations; and 3) the adverse effects should include increased mortality and morbidity observed in people. The central hypothesis is: Ambient air particles are complex mixtures with intrinsic toxicity. In concert with pre-existing inflammation, particulate exposure results in stimulation oflung receptors, release of reactive oxygen species, and pro-inflammatory mediators that lead to local and systemic effects, which ultimately account for the epidemiological associations. Our studies will utilize: 1) the Harvard Ambient Particulate Concentrator, a newly developed device that can increase ambient particle concentrations up to 30X without changing the physical or chemical characteristics of the particles; 2) an urban aerosol typical of the northestern US with ambient fine particle concentrations usually 5-15 gu/m3; 3) animal models of chronic bronchitist, coronary heart disease, and asthma to simulat affected human populations and to elucidate mechanistic effects; 4) established cell, molecular, and systems physiology methods to test mechanistic hypotheses; and 5) analytical capabilities to relate specific particulate constituents to adverse responses. The study consists of 3 projects and 3 cores: 1) Air Particles Cause Death in Animals with Lung Disease; 2) Cardiac Vulneraability due to Ambient Air Particle Exposure; 3) Responses of Inflammation-Primed Lung Cells to Particles; and Ambient Particle Exposure and Characterization Core. The novel application of these technique in coordinates studies will offer new insights into mechanisms of toxicity of ambient air particles.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Program Projects (P01)
Project #
1P01ES008129-01A1
Application #
2018692
Study Section
Environmental Health Sciences Review Committee (EHS)
Project Start
1997-06-28
Project End
2002-05-31
Budget Start
1997-06-28
Budget End
1998-05-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Harvard University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115
Wu, Muzo; Gibbons, John G; DeLoid, Glen M et al. (2017) Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia. Am J Physiol Lung Cell Mol Physiol 313:L138-L153
Bartoli, Carlo R; Nadar, Menaka M; Godleski, John J (2010) Capsule thickness correlates with vascular density and blood flow within foreign-body capsules surrounding surgically implanted subcutaneous devices. Artif Organs 34:857-61
Rhoden, Claudia Ramos; Lawrence, Joy; Godleski, John J et al. (2004) N-acetylcysteine prevents lung inflammation after short-term inhalation exposure to concentrated ambient particles. Toxicol Sci 79:296-303
Pope 3rd, C Arden; Burnett, Richard T; Thurston, George D et al. (2004) Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation 109:71-7
Ning, Yaoyu; Tao, Florence; Qin, Guozhong et al. (2004) Particle-epithelial interaction: effect of priming and bystander neutrophils on interleukin-8 release. Am J Respir Cell Mol Biol 30:744-50
Wellenius, Gregory A; Coull, Brent A; Godleski, John J et al. (2003) Inhalation of concentrated ambient air particles exacerbates myocardial ischemia in conscious dogs. Environ Health Perspect 111:402-8
Savage, Sara T; Lawrence, Joy; Katz, Tracy et al. (2003) Does the Harvard/U.S. Environmental Protection Agency Ambient Particle Concentrator change the toxic potential of particles? J Air Waste Manag Assoc 53:1088-97
Saldiva, Paulo H N; Clarke, Robert W; Coull, Brent A et al. (2002) Lung inflammation induced by concentrated ambient air particles is related to particle composition. Am J Respir Crit Care Med 165:1610-7
Batalha, Joao R F; Saldiva, Paulo H N; Clarke, Robert W et al. (2002) Concentrated ambient air particles induce vasoconstriction of small pulmonary arteries in rats. Environ Health Perspect 110:1191-7
Tao, Florence; Kobzik, Lester (2002) Lung macrophage-epithelial cell interactions amplify particle-mediated cytokine release. Am J Respir Cell Mol Biol 26:499-505

Showing the most recent 10 out of 38 publications